Insulin for type 1 and type 2 diabetes

References

Citations

  1. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group (2005). Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. New England Journal of Medicine, 353(25): 2634–2653.

  2. Ratner RE, et al. (2000). Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care, 23(5): 639–643.

  3. Cheng AYY, Zinman B (2001). Insulin for treating type 1 and type 2 diabetes. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 323–343. Hamilton, ON: BC Decker.

  4. Fanelli CG, et al. (2002). Administration of neutral protamine hagedorn insulin at bedtime versus with dinner in type 1 diabetes mellitus to avoid nocturnal hypoglycemia and improve control. Annals of Internal Medicine, 136(7): 504–514.



Author: Robin Parks, MSLast Updated: January 23, 2008
Medical Review: Caroline S. Rhoads, MD - Internal Medicine
Matthew I. Kim, MD - Endocrinology & Metabolism

© 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.

Click here to learn about Healthwise
Click here to learn about Healthwise
Topic Contents
 Examples
 How It Works
 Why It Is Used
 How Well It Works
 Side Effects
 What To Think About
 References